Latest News
SUBMITTED COMMENTS and LETTERS
PRESS
RELEASES
MEDIA
COVERAGE
REMEDY
BLOG
Partnering with hospitals and clinics to share the U.S. Pain mission
Earlier this fall, longtime New Jersey ambassador Jeannette Rotondi and her husband, Dennis, coordinated with Rutgers University’s Behavior Health Center to share U.S. Pain Foundation materials and information during the center’s Wellness Month,...
Coalition applauds Florida bill to prevent medication interruptions
U.S. Pain is part of a coalition of 41 patient and provider groups supporting the “Bait-and-Switch Bill,” SB 360/HB 229, which would require health plans to deliver on the prescription coverage benefits they market and sell for the year. Right now,...
New York adds protections for patients on biologics
After a two-year process calling on New York State lawmakers to update patient protections surrounding biologic treatments, U.S. Pain Foundation is pleased to announce that Gov. Andrew Cuomo signed a biologic substitution bill, Chapter 357 of the...
#DontMix campaign urges caution with meds and alcohol
While it may seem harmless, drinking alcohol with certain prescription medications can cause potentially dangerous adverse effects. To help educate the public on the dangers of mixing prescriptions and alcohol, the National Council on Patient...
#MakeItVisible movement raises awareness, funding for invisible illness
MIDDLETOWN, Conn. (Oct. 6, 2017)—Throughout the month of October, U.S. Pain Foundation is teaming up with Healthline on a campaign to bring awareness to invisible illness and raise money for a good cause. The request: share a photo or video that...
Understanding the new CVS opioid policy
Many in the chronic pain community expressed concern after CVS pharmacy announced this month that it will limit opioid prescriptions to seven days for acute or new conditions. The wording of the new policy is as follows: “This program will include...